Yamashita H - Search Results

1

Successful Control of Carcinoma of Unknown Primary with Axitinib, a Novel Molecular-Targeted Agent: A Case Report.

Honda A, Yoshimi A, Ushiku T, Shinoda Y, Kawano H, Toya T, Kogure Y, Yamashita H, Kume H, Nannya Y, Kurokawa M. Honda A, et al. Among authors: yamashita h. Chemotherapy. 2014;60(5-6):342-5. doi: 10.1159/000437135. Epub 2015 Aug 18. Chemotherapy. 2014. PMID: 26288144

2

Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.

Yamashita H, Izutsu K, Nakamura N, Shiraishi K, Chiba S, Kurokawa M, Tago M, Igaki H, Ohtomo K, Nakagawa K. Yamashita H, et al. Ann Hematol. 2006 Aug;85(8):523-9. doi: 10.1007/s00277-006-0114-4. Epub 2006 May 12. Ann Hematol. 2006. PMID: 16691398

3

Histological changes after single high-dose irradiation for squamous cell carcinoma arising from a burn scar.

Kan Y, Yamashita H, Le Pavoux A, Ushiku T, Ohtomo K, Nakagawa K. Kan Y, et al. Among authors: yamashita h. Med Oncol. 2010 Mar;27(1):86-90. doi: 10.1007/s12032-009-9176-1. Epub 2009 Feb 13. Med Oncol. 2010. PMID: 19214812

4

Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients.

Omori M, Yamashita H, Shinohara A, Kurokawa M, Takita J, Hiwatari M, Nakagawa K. Omori M, et al. Among authors: yamashita h. Springerplus. 2013 Aug 30;2(1):424. doi: 10.1186/2193-1801-2-424. eCollection 2013. Springerplus. 2013. PMID: 24040584 Free PMC article.

5

Unique radiation dermatitis related to total body irradiation by helical tomotherapy.

Takenaka R, Yamashita H, Toya T, Haga A, Shibata S, Kurokawa M, Ootomo K, Nakagawa K. Takenaka R, et al. Among authors: yamashita h. J Dermatol. 2016 Nov;43(11):1376-1377. doi: 10.1111/1346-8138.13396. Epub 2016 Apr 30. J Dermatol. 2016. PMID: 27130847 No abstract available.

6

Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma.

Kaburaki T, Taoka K, Matsuda J, Yamashita H, Matsuda I, Tsuji H, Tanaka R, Nakazaki K, Nakamura F, Kamiya K, Kurokawa M, Ohtomo K, Aihara M. Kaburaki T, et al. Among authors: yamashita h. Br J Haematol. 2017 Oct;179(2):246-255. doi: 10.1111/bjh.14848. Epub 2017 Jul 12. Br J Haematol. 2017. PMID: 28699673 Free article. Clinical Trial.

7

Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer.

Makino K, Sato Y, Takenaka R, Yamashita H, Akiyama Y, Yamada Y, Nakamura M, Kawai T, Yamada D, Suzuki M, Kume H. Makino K, et al. Among authors: yamashita h. Urol Int. 2023;107(5):440-446. doi: 10.1159/000521723. Epub 2022 Mar 15. Urol Int. 2023. PMID: 35290980 Free PMC article.

8

Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis.

Noda M, Taguchi S, Shiraishi K, Fujimura T, Naito A, Kawai T, Kamei J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Nakagawa T, Yamashita H, Nakagawa K, Abe O, Fukuhara H, Kume H. Noda M, et al. Among authors: yamashita h. Strahlenther Onkol. 2024 Aug;200(8):676-683. doi: 10.1007/s00066-023-02192-5. Epub 2024 Jan 5. Strahlenther Onkol. 2024. PMID: 38180494 Free PMC article.

9

Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer.

Kawai T, Taguchi S, Nozaki K, Kimura N, Oshina T, Iwaki T, Matsui H, Niimi A, Kamei J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Kaneko T, Sawayanagi S, Nakayama H, Minamimoto R, Yamashita H, Miyazaki H, Fujimura T, Nakagawa T, Kume H. Kawai T, et al. Among authors: yamashita h. Prostate Int. 2023 Dec;11(4):239-246. doi: 10.1016/j.prnil.2023.10.002. Epub 2023 Oct 21. Prostate Int. 2023. PMID: 38196558 Free PMC article.

10

In Curative Stereotactic Body Radiation Therapy for Prostate Cancer, There Is a High Possibility That 45 Gy in Five Fractions Will Not Be Tolerated without a Hydrogel Spacer.

Sawayanagi S, Yamashita H, Ogita M, Kawai T, Sato Y, Kume H. Sawayanagi S, et al. Among authors: yamashita h. Cancers (Basel). 2024 Apr 11;16(8):1472. doi: 10.3390/cancers16081472. Cancers (Basel). 2024. PMID: 38672553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,603 results

Search Page

Filters